What Are Eye Diseases?

Eye diseases are pathological conditions of the ocular tissues and the visual pathway that degrade or destroy sight. They span disorders of the transparent front of the eye, such as cataract and corneal dystrophy, disorders of intraocular pressure and the optic nerve, and disorders of the light-sensing retina at the back of the globe. Clinically they are grouped by anatomy, by mechanism, and by whether vision loss is reversible. The category matters to engineering because the eye is the one organ whose interior can be imaged optically at micrometer resolution through an intact body surface, which has made ophthalmology an early adopter of optical instrumentation, image processing, and automated diagnosis.

Most sight-threatening disease is chronic and age-related. The Centers for Disease Control and Prevention's summary of common eye disorders identifies cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy as the conditions responsible for most vision impairment in adults, alongside refractive error, which is correctable. Projections from the National Eye Institute on rising vision loss in an aging population anticipate the affected population roughly doubling over the coming decades, which is the demographic pressure behind work on screening automation and low-cost imaging.

Glaucoma

Glaucoma is a family of optic neuropathies in which retinal ganglion cell axons are progressively lost, usually in association with elevated intraocular pressure. Open-angle glaucoma, the most common form, is asymptomatic until peripheral vision is already gone, so detection depends on measurement rather than on patient complaint. Diagnosis combines tonometry for pressure, standard automated perimetry to map the visual field, and optical coherence tomography to quantify thinning of the retinal nerve fiber layer. Management targets pressure through topical drugs, laser trabeculoplasty, or surgical drainage devices, since no treatment restores lost axons. Instrumentation research concentrates on continuous pressure sensing, including contact-lens and implanted microelectromechanical sensors, because a single clinic reading poorly represents daily pressure variation.

Macular Degeneration

Age-related macular degeneration attacks the macula, the small central region of retina responsible for high-acuity vision. The National Eye Institute's account of age-related macular degeneration distinguishes a slow atrophic form, which accounts for most cases and advances through early and intermediate stages, from a neovascular form in which abnormal choroidal vessels leak beneath the retina and vision falls quickly. Anti-VEGF injections have made the neovascular form treatable, while complement-pathway drugs approved in the United States since 2023 slow the growth of atrophic lesions without restoring lost vision, and cell replacement remains experimental. Grading relies on fundus photography and on cross-sectional OCT volumes, a data type that supports automated drusen quantification and layer segmentation.

Retinopathy

Retinopathy covers damage to the retinal microvasculature, most often from diabetes and less often from hypertension, prematurity, or sickle cell disease. In diabetic retinopathy, described by the National Eye Institute's diabetic retinopathy resource, chronic hyperglycemia weakens capillary walls, producing microaneurysms and hemorrhages, then ischemia that drives proliferation of fragile new vessels. Because the disease is silent for years and the treatable window is defined by severity grade, annual dilated examination is standard for people with diabetes. Retinopathy of prematurity follows a different mechanism, in which incomplete retinal vascularization in preterm infants is disrupted by supplemental oxygen. Both conditions are graded from color fundus images, and diabetic retinopathy screening was the first medical application in which an autonomous image-classification system received regulatory clearance to make a diagnostic call without physician review.

Applications

Work on eye diseases intersects with several engineering fields, including:

• Biomedical optics, covering optical coherence tomography, adaptive-optics imaging, and fundus camera design
• Medical image analysis, including vessel segmentation, lesion detection, and automated disease grading
• Machine learning for population screening in settings without an ophthalmologist
• Implantable and wearable sensors for intraocular pressure monitoring
• Retinal prosthetics and optogenetic vision restoration
• Drug delivery devices for sustained intraocular release